Avacta Group (LON:AVCT) Trading Down 13.2% – Time to Sell?

Avacta Group Plc (LON:AVCTGet Free Report) shares were down 13.2% on Tuesday . The stock traded as low as GBX 33 ($0.42) and last traded at GBX 33 ($0.42). Approximately 2,673,765 shares were traded during trading, an increase of 96% from the average daily volume of 1,364,946 shares. The stock had previously closed at GBX 38 ($0.48).

Avacta Group Trading Down 13.2 %

The stock has a market cap of £125.37 million, a price-to-earnings ratio of -4.25 and a beta of 1.12. The firm’s 50 day moving average is GBX 47.33 and its two-hundred day moving average is GBX 53.41. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53.

About Avacta Group

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

Featured Articles

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.